Otsuka (OTCMKTS:OTSKY) Shares Climb 6.9% – Here’s What Happened

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY)’s stock price was up 6.9% during mid-day trading on Thursday. The stock traded as high as $38.5220 and last traded at $38.5220. Approximately 2,460 shares were traded during mid-day trading, a decline of 94% from the average daily volume of 41,980 shares. The stock had previously closed at $36.05.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Otsuka from a “hold” rating to a “strong-buy” rating in a report on Friday, October 9th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy”.

Otsuka Stock Performance

The company has a market cap of $40.93 billion, a price-to-earnings ratio of 15.30, a PEG ratio of 2.64 and a beta of 0.09. The firm’s 50-day moving average price is $37.32 and its 200 day moving average price is $35.55. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.65 and a current ratio of 2.21.

Otsuka (OTCMKTS:OTSKY) last posted its earnings results on Friday, July 31st. The company reported $0.70 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.19. Otsuka had a return on equity of 12.86% and a net margin of 15.50%. The firm had revenue of $4.41 billion for the quarter, compared to analyst estimates of $3.95 billion. Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. On average, sell-side analysts anticipate that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 2.23 EPS for the current year.

Otsuka Company Profile

Otsuka Holdings Co, Ltd. is a Japan-based healthcare company that oversees the Otsuka Group’s pharmaceutical, nutraceutical and consumer health businesses. The company’s operations are primarily conducted through subsidiaries, including Otsuka Pharmaceutical Co, Ltd., which researches, develops, manufactures and markets prescription medicines, over-the-counter products and health-related foods.

Otsuka’s pharmaceutical activities focus on areas such as psychiatry, oncology, cardiovascular and renal medicine, and several other specialized therapeutic fields.